Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

NEXT STORY
Brandywine Realty Trust Announces Fourth Quarter, Full Year 2020 Results, Initiates 2021 Guidance, and Announces Investment Activity
PREV STORY
Sanofi Steps in to Help Pfizer Vaccine Production
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office

author_avatar
NASDAQ Market News

Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG

author_avatar
NASDAQ Market News

Bellerophon Therapeutics Added to Russell 3000® and Microcap® Indexes

author_avatar
NASDAQ Market News